As scientists, we are accustomed to learning something new about targets (and the modulation thereof) that moves the field forward...
Read more
In the perpetual and never-ending race by the healthcare sector to unearth new approaches and therapeutics to address disease, one...
Read more
HotSpot’s trip to Barcelona for the recent European Society of Medical Oncology (ESMO) Annual Meeting was no ‘European Vacation,’ but...
Read more
As Boston’s weather has started its turn from the frigid darkness that is a northeast winter to the longer days...
Read more
At HotSpot, we’re harnessing insights from nature by pinpointing specialized protein on/off switches, or pockets, called “natural hotspots.” To date,...
Read more
Signaling pathways are the intricate networks that govern cell behavior, lying at the crux of cell function. They are used...
Read more
The American Cancer Society for Oncology (ASCO) annual meeting is among the highlights of the clinical oncology calendar. The meeting...
Read more
At HotSpot, we are committed to building something we believe is truly distinctive, setting ourselves apart from our peers in...
Read more
The phrase ‘build it and they will come’ dates all the way back to the Old Testament, and in more...
Read more
HotSpot Therapeutics recently announced FDA clearance of our Investigational New Drug (IND) application for HST-1011, our small molecule allosteric inhibitor...
Read more